Infantile choroidocerebral calcification syndrome

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:1313OMIM:215480G93.8
Who is this for?
Show terms as
8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Infantile choroidocerebral calcification syndrome, also known as Infantile Brain Calcification or Pseudo-TORCH syndrome, is an extremely rare genetic disorder characterized by intracranial (brain) calcifications and ocular abnormalities that present in infancy. The condition mimics the clinical features of congenital TORCH infections (Toxoplasmosis, Other agents, Rubella, Cytomegalovirus, Herpes simplex) but occurs without evidence of an infectious cause. Key body systems affected include the central nervous system and the eyes. Neurological features typically include microcephaly (abnormally small head), cerebral calcifications visible on imaging, seizures, and significant developmental delay or intellectual disability. Ocular findings may include chorioretinal abnormalities and other eye involvement. The condition is present from birth or early infancy, and affected infants often show poor neurological development, spasticity, and failure to thrive. Brain imaging reveals characteristic calcifications, particularly in the basal ganglia and periventricular regions, along with possible cerebral atrophy and white matter abnormalities. Some cases may also present with hepatosplenomegaly and thrombocytopenia, further mimicking a congenital infection. There is currently no specific curative treatment for infantile choroidocerebral calcification syndrome. Management is supportive and symptomatic, focusing on seizure control with antiepileptic medications, physical and occupational therapy for developmental support, and ophthalmologic monitoring. Genetic counseling is recommended for affected families. The prognosis is generally poor, with significant neurological impairment in most reported cases.

Clinical phenotype terms— hover any for plain English:

Inheritance

Autosomal recessive

Passed on when both parents carry the same gene change; often skips generations

Age of Onset

Neonatal

Begins at or shortly after birth (first 4 weeks)

Orphanet ↗OMIM ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for Infantile choroidocerebral calcification syndrome.

View clinical trials →

No actively recruiting trials found for Infantile choroidocerebral calcification syndrome at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Infantile choroidocerebral calcification syndrome community →

No specialists are currently listed for Infantile choroidocerebral calcification syndrome.

View NORD Rare Disease Centers ↗Undiagnosed Disease Network ↗

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Infantile choroidocerebral calcification syndrome.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Infantile choroidocerebral calcification syndromeForum →

No community posts yet. Be the first to share your experience with Infantile choroidocerebral calcification syndrome.

Start the conversation →

Latest news about Infantile choroidocerebral calcification syndrome

No recent news articles for Infantile choroidocerebral calcification syndrome.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about Infantile choroidocerebral calcification syndrome

What is Infantile choroidocerebral calcification syndrome?

Infantile choroidocerebral calcification syndrome, also known as Infantile Brain Calcification or Pseudo-TORCH syndrome, is an extremely rare genetic disorder characterized by intracranial (brain) calcifications and ocular abnormalities that present in infancy. The condition mimics the clinical features of congenital TORCH infections (Toxoplasmosis, Other agents, Rubella, Cytomegalovirus, Herpes simplex) but occurs without evidence of an infectious cause. Key body systems affected include the central nervous system and the eyes. Neurological features typically include microcephaly (abnormally

How is Infantile choroidocerebral calcification syndrome inherited?

Infantile choroidocerebral calcification syndrome follows a autosomal recessive inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.

At what age does Infantile choroidocerebral calcification syndrome typically begin?

Typical onset of Infantile choroidocerebral calcification syndrome is neonatal. Age of onset can vary across affected individuals.